WHAT: A 2-day conference that will bring together clinicians and researchers to examine cutting-edge scientific findings about drug abuse and addiction and their application to clinical practice.
WHY: As in other fields of medicine, a gap exists in the drug abuse treatment field between clinical practice and scientific research. By bringing together leading drug abuse treatment clinicians and researchers, this conference will provide an opportunity to further bridge that gap.
HOSTS: NIDA and the Florida Node of the NIDA Clinical Trials Network (CTN), located at the University of Miami, are sponsoring the conference
WHEN: Monday and Tuesday, June 6-7, 2005
WHERE: The Sheraton Bal Harbour Hotel, 9701 Collins Avenue, Bal Harbour, Florida
WHO SHOULD ATTEND: Drug treatment counselors, social workers, healthcare providers, criminal justice staff, marriage and family counselors, public health workers, physicians, researchers interested in drug abuse and addiction issues, and the media are encouraged to attend.
INFO: BLENDING CONFERENCE OVERVIEW
Nora D. Volkow, M.D., Director, National Institute on Drug Abuse (NIDA), will present the opening plenary session, "Progress in Translating Drug Abuse Research into Clinical Practice," in the Grand Ballroom at 9:30 a.m. on Monday, June 6, 2005.
Below is a partial list of topics by NIDA-supported investigators.
| Monday, June 6 | (Concurrent Panel Sessions) |
| 11:15 a.m. - 1:00 p.m. | Evidence-Based Treatment for Co-Occurring Anxiety and Mood Disorders Gender-Specific Treatment for Women Newest Findings on the Effectiveness of Buprenorphine Detoxification, Motivational Enhancement Therapy and Motivational Incentives Nicotine Treatment in Substance Abuse Treatment Settings |
| 1:00 p.m. - 2:30 p.m. | Treatment Improvement Through Applied Research in Community Based Service Settings |
| (Concurrent Workshops) | |
| 2:30 p.m. - 5:30 p.m. | Motivational Incentives Brief Strategic Family Therapy in the Treatment of Drug Abusing Adolescents An Introduction to Motivational Interviewing |
| Tuesday, June 7 | (Concurrent Panel Sessions) |
| 11:15 a.m. - 1:00 p.m. | Research on Successful Dissemination Challenges of Clinical Supervision of Empirically Supported Treatments Emerging Drug Problems in Florida: Methamphetamine and Prescription Drugs Drugs, the Brain, and Behavior Assessment and Treatment of ADHD with Substance Abuse Treatment in Drug Abusing Adolescents |
| (Workshop) | |
| 2:30 p.m. - 5:30 p.m. | HIV Interventions for Community Treatment Programs (CTP) |
Other highlights of the meeting include:
- Re-Considering Addiction Treatment: Quality, Accountability, and Outcomes in a Chronic Care Perspective, Tuesday, June 7, 1:00 p.m. - 2:30 p.m. by luncheon speaker, A. Thomas McClellan, Ph.D., Director, Treatment Research Institute.
- A Conversation with Bill Miller, Tuesday, June 7, 2:30-5:30 p.m. Dr. Miller has spent 30 years developing, evaluating and disseminating innovative and evidence-based treatments for substance use disorders. Among the treatments he has studied are behavioral self-control training, cognitive-behavior therapy, the community reinforcement approach, covert sensitization, and motivational interviewing. This 3-hour unstructured session will include a brief overview of his work and open conversation.
- Updating Prevention of HIV Infection in Drug Users, Tuesday, June 7, 10-11 a.m. Dr. David Vlahov has been Principal Investigator of the ALIVE Study, which, for 19 years, has recruited and followed over 3,000 injection drug users in Baltimore for a variety of health outcomes. He will discuss how clinicians can incorporate the latest research about HIV prevention and treatment into their care of drug-using patients.
In addition, while the conference will be conducted in English, a number of sessions will also be translated live and made available in Spanish.